Abstract
A total of 2,571 barrows and gilts (PIC 337 × 1050) were used to determine the effects of porcine circovirus type 2 vaccine (PCV2) on nursery and finishing pigs that were challenged with porcine respiratory and reproductive syndrome (PRRS). Treatments were arranged in a 2 × 2 factorial design with main effects of gender (barrow or gilt) and vaccine (PCV2 vaccinates or non-vaccinates). Vaccinated pens received 2 doses of commercial PCV2 vaccine (Circumvent PCV, Intervet Inc., Millsboro, DE) according to label directions on d 1 and 22 in the nursery. All pigs were also inoculated on d 30 with serum containing PRRS virus as part of this production system’s protocol. Barns were double stocked from d 0 to 51. On d 51, gilts were moved to an adjacent facility and barrows were split into 2 pens. In the period after the initial PCV2 vaccination (d 0 to 15), no difference in ADG, ADFI, or F/G was observed (P > 0.13) between genders or between vaccinates and non-vaccinates. However, in the period after the second PCV2 vaccination (d 15 to 29), vaccinated pigs had decreased (P < 0.02) ADG compared with non-vaccinates as a result of decreased (P < 0.04) ADFI. Gilts also had increased (P < 0.04) ADG and ADFI compared with barrows. In the period after all pigs were inoculated with PRRS virus (d 29 to 50), PCV2 vaccinates had improved (P < 0.001) F/G over non-vaccinates and a trend (P < 0.08) for improved ADG. Gilts had poorer (P < 0.01) F/G compared with barrows from d 29 to 50. Over the entire 50-d nursery portion of the study, no differences were observed (P > 0.61) for ADG, ADFI, or final weight among gender or PCV2 vaccinates and non-vaccinates. However, F/G was improved (P < 0.001) with PCV2 vaccination. Pig weights on d 71 and 99 were increased (P < 0.001) in vaccinates compared with non-vaccinates, and barrows had increased (P < 0.001) BW compared with gilts on d 99. At the conclusion of the study (d 132 for barrows and d 142 for gilts), the percentage of pigs remaining on test was decreased (P < 0.001) in non-vaccinated pens compared with vaccinated pens (70.2% vs. 94.7%, respectively). This study suggests that despite the decrease in performance related to the second vaccination of PCV2, the second vaccination improved final performance and decreased the number of removals due to the PRRS health challenge.; Swine Day, Manhattan, KS, November 19, 2009
Highlights
Porcine circovirus disease (PCVD) caused by porcine circovirus type 2 (PCV2) has recently become a major disease affecting growing pigs worldwide
In the period after the second PCV2 vaccination (d 15 to 29), vaccinated pigs had decreased (P < 0.02) ADG compared with non-vaccinates as a result of decreased (P < 0.04) ADFI
Gilts had increased (P < 0.04) ADG and ADFI compared with barrows
Summary
Porcine circovirus disease (PCVD) caused by porcine circovirus type 2 (PCV2) has recently become a major disease affecting growing pigs worldwide. Recent research has shown increases in growth rates and finals weights of finishing pigs vaccinated with PCV2 vaccine (Jacela et al, 20075, 20086; Potter et al, 20087). Kane et al (20088) reported a decrease in nursery pig ADG due to decreases in feed intake after vaccination for PCV2 and Mycoplasma hyopneumoniae. This indicates that there may be improvements in finishing pig performance with PCV2 vaccination, there may be some expense due to lost nursery performance. Additional health challenges could affect the response to PCV2 vaccination. The objective of this study was to determine the effects of PCV2 vaccination in gilts and barrows challenged with porcine respiratory and reproductive syndrome (PRRS)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Kansas Agricultural Experiment Station Research Reports
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
